Skip to main content
SpringerLink
Log in

An Overview of Mood Disorders in the DSM-5

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

The process of revising the DSM, which is based on new findings in the literature and experience with the current classification, is initiated every 12–18 years. The process for the revision of DSM-IV to the DSM-5 began in 2006—after a series of meeting proceedings and monographs were published during the previous 3 years—with the appointment of diagnostic group chairs by Director Dr. David Kupfer and Vice Director Dr. Darrel Regier. Members were recruited for workgroups to review the existing DSM-IV, to decide what worked well and which areas needed change, to review the available literature and data, and to propose changes based on an appropriate level of evidence in the literature proportional to the significance of the change. At the halfway point in this process, the Mood Disorders Workgroup has made tentative recommendations to be tested in field trials. These recommendations and some of the basis for them are discussed in this review. Final decisions await the data from field trials, possible revisions by the workgroups, and action by the task force. This article describes some of the recommendations made by the Mood Disorders Workgroup at this point in the process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Moreno C, Laje G, Blanco C, et al.: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch gen Psychiatry 2007, 64:1032–1039.

    Article  PubMed  Google Scholar 

  2. Spearing M, Post RM, Leverich GS, et al.: Modification of the Clinical Global Impression (CGI) scale for use in bipolar illness: the CGI-BP. Psychiatry Res 1997, 73:159–171.

    Article  CAS  PubMed  Google Scholar 

  3. Kroenke K, Spitzer RL, Williams JB, Lowe B: The Patient Health Questionnaire, somatic, anxiety and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010, 32:345–359.

    Article  PubMed  Google Scholar 

  4. Keller MB, Lavori PW, Friedman B, et al.: The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987, 44:540–548.

    CAS  PubMed  Google Scholar 

  5. Altman EG, Hedeker D, Peterson JL, Davis JM: The Altman Self-Rating Mania Scale. Biol Psychiatry 1997, 42:948–955.

    Article  CAS  PubMed  Google Scholar 

  6. McKibbin C, Patterson T, Jeste DV: Assessing disability in older patients with schizophrenia: results from the WHODAS II. J Nerv Ment Dis 2004, 192:405–413.

    Article  PubMed  Google Scholar 

  7. • Fava M, Rush AJ, Alpert JD, et al.: Difference in treatment outcome in patients with anxious vs non-anxious depression: a STAR*D report. Am J Psychiatry 2008, 165:342–351. This analysis of STAR*D outcome data in patients with major depression showed that patients with higher levels of anxiety had significantly poorer responses to antidepressant medications.

    Article  PubMed  Google Scholar 

  8. Papakostas GI, McGrath P, Stewart J, et al.: Psychic and somatic anxiety as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res 2008, 161:116–120.

    Article  CAS  PubMed  Google Scholar 

  9. Howland RH, Rush AJ, Wisniewshi SR, et al.: Concurrent anxiety and substance abuse disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend 2009, 99:248–260.

    Article  PubMed  Google Scholar 

  10. Yang H, Chuzi S, Sinicropi-Yao L, et al.: Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. Eur Arch Psychiatry Clin Neurosci 2010, 260:145–150.

    Article  PubMed  Google Scholar 

  11. Thase ME: Update of partial response in depression. J Clin Psychiatry 2009, 70(Suppl 6):4–9.

    Article  PubMed  Google Scholar 

  12. • Coryell W, Soloman DA, Fiedorowicz JG, et al.: Anxiety and outcome in bipolar disorder. Am J Psychiatry 2009, 166:1238–1243. This analysis of the Collaborative Depression Study of bipolar patients showed that high psychic and somatic anxiety scores on the SADS-C scales at baseline are associated with a stepwise increase in time spent in a depressive episode over 5-year periods during a 20-year follow-up.

    Article  PubMed  Google Scholar 

  13. Fawcett J, Scheftner WA, Fogg L, et al.: Time related predictors of suicide in major depressive disorder. Am J Psychiatry 1990, 147:1189–1194.

    CAS  PubMed  Google Scholar 

  14. Busch KA, Fawcett J, Jacobs D: Clinical correlates of inpatient suicide. J Clin Psychiatry 2003, 64:14–19.

    Article  PubMed  Google Scholar 

  15. Simon GE, Hunkeler E, Fireman B, et al.: Risk of suicide and suicide death in patients treated for bipolar disorder. Bipolar Disord 2007, 9:526–530.

    Article  PubMed  Google Scholar 

  16. • Pfeiffer PN, Ganoczy D, Ligen M, et al.: Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety 2009, 26:752–757. This follow-up study of more than 800,000 depressed veterans found significantly higher rates of suicide among patients with comorbid generalized anxiety disorder, panic disorder, and anxiety NOS disorder, but not in the case of other anxiety disorders, including post-traumatic stress disorder. Furthermore, patients receiving antianxiety treatment had elevated rates of suicide, and these rates were elevated further if the patient was receiving high-dose antianxiety medications, suggesting a relationship between anxiety severity and suicide risk.

    Article  PubMed  Google Scholar 

  17. Clayton PJ, Grove WM, Coryell WM, et al.: Follow up and family study of anxious depression. Am J Psychiatry 1991, 148:1512–1517.

    CAS  PubMed  Google Scholar 

  18. Oquendo MA, Malone KM, Ellis SP, et al.: Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry 1999, 156:190.

    CAS  PubMed  Google Scholar 

  19. Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997, 170:205–228.

    Article  CAS  PubMed  Google Scholar 

  20. Coryell W, Young EA: Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 2005, 66:412–417.

    Article  PubMed  Google Scholar 

  21. Oquendo M, Currier D, Mann JJ: Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand 2006, 114:151–158.

    Article  CAS  PubMed  Google Scholar 

  22. Marangell LB, Bauer MS, Dennehy EB, et al.: Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed up to 2 years. Bipolar Disord 2006, 8:566–575.

    Article  PubMed  Google Scholar 

  23. Baldessarini RJ, Hennen J: Genetics of suicide: an overview. Harv Rev Psychiatry 2004, 12:1–13.

    PubMed  Google Scholar 

  24. Brent DS, Melham N: Familial transmission of suicidal behavior. Psychiatr Clin North Am 2008, 31:157–177.

    Article  PubMed  Google Scholar 

  25. Sarrchiapone M, Carli V, Giannantonio MD, Roy A: Risk factors for attempting suicide in prisoners. Suicide Life Threat Behav 2009, 39:343–350.

    Article  Google Scholar 

  26. Roy A, Gorodelsky E, Yuan Q, et al.: Neuropsychopharmacology 2010, 35:1674–1683.

    CAS  PubMed  Google Scholar 

  27. Isometsa ET, Lonnqyist JK: Suicide attempts preceding suicide. Br J Psychiatry 1998, 173:531–535.

    Article  CAS  PubMed  Google Scholar 

  28. Isometsa ET, Heikkinen ME, Martunen MJ, et al.: The last appointment before suicide: is suicide intent communicated? Am J Psychiatry 1995, 152:919–922.

    CAS  PubMed  Google Scholar 

  29. Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007, 356:1711–1722.

    Article  CAS  PubMed  Google Scholar 

  30. Truman CJ, Goldberg JF, Ghaemi SN, et al.: Self-reported history of manic/hypomanic switch associated with antidepressant use: data from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007, 68:1472–1479.

    Article  PubMed  Google Scholar 

  31. Holma KM, Melartin TK, Holma IA, Isometsa ET: Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5 year prospective study. J Clin Psychiatry 2008, 69:1267–1275.

    Article  PubMed  Google Scholar 

  32. Ghaemi SN, Ostracher MM, El-Mallakh RS, et al.: Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010, 71:372–380.

    Article  PubMed  Google Scholar 

  33. Goldberg JF, Perlis RH, Bowden CL, et al.: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2009, 166:173–181.

    Article  PubMed  Google Scholar 

  34. Calabrese JR, Muzina DJ, Kemp DE, et al.: Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed 2006, 15:38.

    Google Scholar 

  35. Zimmermann P, Brucki T, Nocon A, et al.: Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 2009, 66:1341–1352.

    Article  PubMed  Google Scholar 

  36. Agosti V, Stewart JW: Hypomania with and without dysphoria: comparison and clinical characteristics of respondents from a national community sample. J Affect Disord 2008, 108:177–182.

    Article  PubMed  Google Scholar 

  37. Kendler KS, Myers J, Zisook S: Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry 2008, 165:1449–1455.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Dr. Fawcett has served on a board for Merck & Co.

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of New Mexico School of Medicine, MSC 09 5030, 1 University of New Mexico, Albuquerque, NM, 87131, USA

    Jan Fawcett

Authors
  1. Jan Fawcett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Fawcett.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fawcett, J. An Overview of Mood Disorders in the DSM-5 . Curr Psychiatry Rep 12, 531–538 (2010). https://doi.org/10.1007/s11920-010-0154-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-010-0154-2

Keywords

Search

Navigation